Surgery Today

, Volume 44, Issue 8, pp 1392–1399 | Cite as

Clinicopathological features and treatment outcomes of metastatic tumors in the stomach

  • Tsutomu NamikawaEmail author
  • Kazuhiro Hanazaki
Review Article


The metastasis of tumors to the stomach is rare, which underlies the clinical problems regarding their diagnosis and treatment. The present review summarizes the current knowledge regarding the clinicopathological characteristics, therapeutic strategies and outcomes for metastatic tumors in the stomach. The primary malignancies of the metastatic tumors in the stomach were most often breast cancers (27.9 %), followed by lung cancer (23.8 %), esophageal cancer (19.1 %), renal cell carcinoma (RCC; 7.6 %) and malignant melanoma (7.0 %). In cases of breast cancer and RCC as the primary malignancy, the median interval between the treatment of the primary tumor and diagnosis of the metastatic tumor in the stomach (IPM) was 50–78 and 75.6 months, respectively, highlighting the fact that the metastatic spread to the stomach may occur many years after the initial treatment of the cancer. In nine patients with metastatic gastric tumors arising from ovarian cancer, an endoscopic examination revealed submucosal tumors in six patients (66.7 %), with a median IPM of 30 months. Appropriate systemic treatment for these tumors is the preferred therapeutic strategy. Although solitary metachronous gastric metastasis several years after treatment of the primary tumor is an exceptionally rare event, surgical resection of metastatic gastric tumors may be recommended to control hemorrhaging or for selected tumors.


Gastric metastasis Metastatic tumor Surgery Outcome 


Conflict of interest

The authors have no conflicts of interest to declare.


  1. 1.
    Kobayashi O, Murakami H, Yoshida T, Cho H, Yoshikawa T, Tsuburaya A, et al. Clinical diagnosis of metastatic gastric tumors: clinicopathologic findings and prognosis of nine patients in a single cancer center. World J Surg. 2004;28:548–51.PubMedCrossRefGoogle Scholar
  2. 2.
    De Palma GD, Masone S, Rega M, Simeoli I, Donisi M, Addeo P, et al. Metastatic tumors to the stomach: clinical and endoscopic features. World J Gastroenterol. 2006;12:7326–8.PubMedGoogle Scholar
  3. 3.
    Oda I, Kondo H, Yamao T, Saito D, Ono H, Gotoda T, et al. Metastatic tumors to the stomach: analysis of 54 patients diagnosed at endoscopy and 347 autopsy cases. Endoscopy. 2001;33:507–10.PubMedCrossRefGoogle Scholar
  4. 4.
    Namikawa T, Munekage M, Kitagawa H, Okabayashi T, Kobayashi M, Hanazaki K. Metastatic gastric tumors arising from renal cell carcinoma: clinical characteristics and outcome of this uncommon disease. Oncol Lett. 2012;4:631–6.PubMedCentralPubMedGoogle Scholar
  5. 5.
    Taal BG, Peterse H, Boot H. Clinical presentation, endoscopic features, and treatment of gastric metastases from breast carcinoma. Cancer. 2000;89:2214–21.PubMedCrossRefGoogle Scholar
  6. 6.
    Namikawa T, Iwabu J, Kitagawa H, Okabayashi T, Kobayashi M, Hanazaki K, et al. Solitary gastric metastasis from a renal cell carcinoma, presenting 23 years after radical nephrectomy. Endoscopy. 2012;44:E177–8.PubMedCrossRefGoogle Scholar
  7. 7.
    Namikawa T, Kobayashi M, Hanazaki K. Metastatic gastric tumor arising from ovarian cancer. Gastrointest Endosc (in press).Google Scholar
  8. 8.
    Antler AS, Ough Y, Pitchumoni CS, Davidian M, Thelmo W. Gastrointestinal metastases from malignant tumors of the lung. Cancer. 1982;49:170–2.PubMedCrossRefGoogle Scholar
  9. 9.
    Saito T, Iizuka T, Kato H, Watanabe H. Esophageal carcinoma metastatic to the stomach. A clinicopathologic study of 35 cases. Cancer. 1985;56:2235–41.PubMedCrossRefGoogle Scholar
  10. 10.
    Green LK. Hematogenous metastases to the stomach. A review of 67 cases. Cancer. 1990;65:1596–600.PubMedCrossRefGoogle Scholar
  11. 11.
    Campoli PM, Ejima FH, Cardoso DM, Silva OQ, Santana Filho JB, Queiroz Barreto PA, et al. Metastatic cancer to the stomach. Gastric Cancer. 2006;9:19–25.PubMedCrossRefGoogle Scholar
  12. 12.
    Ayantunde AA, Agrawal A, Parsons SL, Welch NT. Esophagogastric cancers secondary to a breast primary tumor do not require resection. World J Surg. 2007;31:1597–601.PubMedCrossRefGoogle Scholar
  13. 13.
    Szynglarewicz B, Ekiert M, Forgacz J, Halon A, Skalik R, Matkowski R. The role of surgery in the treatment of colorectal metastases from primary skin melanoma. Colorectal Dis. 2012;14:e305–11.PubMedCrossRefGoogle Scholar
  14. 14.
    Jung HJ, Lee HY, Kim BW, Jung SM, Kim HG, Ji JS, et al. Gastric metastasis from ovarian adenocarcinoma presenting as a submucosal tumor without ulceration. Gut Liver. 2009;3:211–4.PubMedCentralPubMedCrossRefGoogle Scholar
  15. 15.
    Akce M, Bihlmeyer S, Catanzaro A. Multiple gastric metastases from ovarian carcinoma diagnosed by endoscopic ultrasound with fine needle aspiration. Case Rep Gastrointest Med. 2012;2012:610527.PubMedCentralPubMedGoogle Scholar
  16. 16.
    Kang WD, Kim CH, Cho MK, Kim JW, Lee JS, Ryu SY, et al. Primary epithelial ovarian carcinoma with gastric metastasis mimic gastrointestinal stromal tumor. Cancer Res Treat. 2008;40:93–6.PubMedCentralPubMedCrossRefGoogle Scholar
  17. 17.
    Schwarz RE, Klimstra DS, Turnbull AD. Metastatic breast cancer masquerading as gastrointestinal primary. Am J Gastroenterol. 1998;93:111–4.PubMedCrossRefGoogle Scholar
  18. 18.
    Saunders NJ. Haematemesis due to gastric involvement by metastatic ovarian carcinoma 30 years after removal of the primary tumour. Br J Clin Pract. 1986;40:298–9.PubMedGoogle Scholar
  19. 19.
    Taylor RR, Phillips WS, O’Connor DM, Harrison CR. Unusual intramural gastric metastasis of recurrent epithelial ovarian carcinoma. Gynecol Oncol. 1994;55:152–5.PubMedCrossRefGoogle Scholar
  20. 20.
    Sangha S, Gergeos F, Freter R, Paiva LL, Jacobson BC. Diagnosis of ovarian cancer metastatic to the stomach by EUS-guided FNA. Gastrointest Endosc. 2003;58:933–5.PubMedCrossRefGoogle Scholar
  21. 21.
    Pernice M, Manci N, Marchetti C, Morano G, Boni T, Bellati F, et al. Solitary gastric recurrence from ovarian carcinoma: a case report and literature review. Surg Oncol. 2006;15:267–70.PubMedCrossRefGoogle Scholar
  22. 22.
    Carrara S, Doglioni C, Arcidiacono PG, Testoni PA. Gastric metastasis from ovarian carcinoma diagnosed by EUS-FNA biopsy and elastography. Gastrointest Endosc. 2011;74:223–5.PubMedCrossRefGoogle Scholar
  23. 23.
    Dassen AE, Lips DJ, Hoekstra CJ, Pruijt JF, Bosscha K. FDG-PET has no definite role in preoperative imaging in gastric cancer. Eur J Surg Oncol. 2009;35:449–55.PubMedCrossRefGoogle Scholar
  24. 24.
    Ahmed K, Sussman JJ, Wang J, Schmulewitz N. A case of EUS-guided FNA-related pancreatic cancer metastasis to the stomach. Gastrointest Endosc. 2011;74:231–3.PubMedCrossRefGoogle Scholar
  25. 25.
    Hassan H, Vilmann P, Sharma V. Impact of EUS-guided FNA on management of gastric carcinoma. Gastrointest Endosc. 2010;71:500–4.PubMedCrossRefGoogle Scholar
  26. 26.
    Varadarajulu S, Eloubeidi MA. The role of endoscopic ultrasonography in the evaluation of pancreatico-biliary cancer. Surg Clin North Am. 2010;90:251–63.PubMedCrossRefGoogle Scholar
  27. 27.
    Yamao K. Complications of endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNAB) for pancreatic lesions. J Gastroenterol. 2005;40:921–3.PubMedCrossRefGoogle Scholar
  28. 28.
    Shah JN, Fraker D, Guerry D, Feldman M, Kochman ML. Melanoma seeding of an EUS-guided fine needle track. Gastrointest Endosc. 2004;59:923–4.PubMedCrossRefGoogle Scholar
  29. 29.
    Paquin SC, Gariépy G, Lepanto L, Bourdages R, Raymond G, Sahai AV. A first report of tumor seeding because of EUS-guided FNA of a pancreatic adenocarcinoma. Gastrointest Endosc. 2005;61:610–1.PubMedCrossRefGoogle Scholar
  30. 30.
    Chong A, Venugopal K, Segarajasingam D, Lisewski D. Tumor seeding after EUS-guided FNA of pancreatic tail neoplasia. Gastrointest Endosc. 2011;74:933–5.PubMedCrossRefGoogle Scholar
  31. 31.
    Katanuma A, Maguchi H, Hashigo S, Kaneko M, Kin T, Yane K, et al. Tumor seeding after endoscopic ultrasound-guided fine-needle aspiration of cancer in the body of the pancreas. Endoscopy. 2012;44:E160–1.PubMedCrossRefGoogle Scholar
  32. 32.
    Whithaus K, Fukuoka J, Prihoda TJ, Jagirdar J. Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung. Arch Pathol Lab Med. 2012;136:155–62.PubMedCrossRefGoogle Scholar
  33. 33.
    Putti TC, Pinder SE, Elston CW, Lee AH, Ellis IO. Breast pathology practice: most common problems in a consultation service. Histopathology. 2005;47:445–57.PubMedCrossRefGoogle Scholar
  34. 34.
    Chia SY, Thike AA, Cheok PY, Tan PH. Utility of mammaglobin and gross cystic disease fluid protein-15 (GCDFP-15) in confirming a breast origin for recurrent tumors. Breast. 2010;19:355–9.PubMedCrossRefGoogle Scholar
  35. 35.
    McGregor DK, Khurana KK, Cao C, Tsao CC, Ayala G, Krishnan B, et al. Diagnosing primary and metastatic renal cell carcinoma: the use of the monoclonal antibody ‘Renal Cell Carcinoma Marker’. Am J Surg Pathol. 2001;25:1485–92.PubMedCrossRefGoogle Scholar
  36. 36.
    Jones GE, Strauss DC, Forshaw MJ, Deere H, Mahedeva U, Mason RC. Breast cancer metastasis to the stomach may mimic primary gastric cancer: report of two cases and review of literature. World J Surg Oncol. 2007;5:75.PubMedCentralPubMedCrossRefGoogle Scholar
  37. 37.
    Suzaki N, Hiraki A, Ueoka H, Aoe M, Takigawa N, Kishino T, et al. Gastric perforation due to metastasis from adenocarcinoma of the lung. Anticancer Res. 2002;22:1209–12.PubMedGoogle Scholar
  38. 38.
    Sileri P, D’Ugo S, Blanco Gdel V, Lolli E, Franceschilli L, Formica V, et al. Solitary metachronous gastric metastasis from pulmonary adenocarcinoma: report of a case. Int J Surg Case Rep. 2012;3:385–8.PubMedCentralPubMedCrossRefGoogle Scholar
  39. 39.
    Abdulkader I, Sánchez L, Cameselle-Teijeiro J, Gude F, Chávez JE, López-López R, et al. Cell-cycle-associated markers and clinical outcome in human epithelial cancers: a tissue microarray study. Oncol Rep. 2005;14:1527–31.PubMedGoogle Scholar
  40. 40.
    Chung C, Christianson M. Predictive and prognostic biomarkers with therapeutic targets in breast, colorectal, and non-small cell lung cancers: a systemic review of current development, evidence, and recommendation. J Oncol Pharm Pract; 2013 Mar 14. (Epub ahead of print).Google Scholar

Copyright information

© Springer Japan 2013

Authors and Affiliations

  1. 1.Department of SurgeryKochi Medical SchoolNankokuJapan

Personalised recommendations